4-Octyl itaconate通过调节TLR4/MAPK/NF-κB信号来缓解内皮细胞炎症和LPS诱导的败血症中的屏障功能障碍:4-Octyl
1Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education; Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology; Laboratory for Cardiovascular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Molecular medicine (Cambridge, Mass.)
|June 16, 2025
概括
4-octyl itaconate (4-OI) 通过减少炎症和保持内皮屏障完整性,有效治疗败血症引起的血管损伤. 这种代谢物衍生物在毒症模型中有望提高生存率.
科学领域:
- 内分泌学和新陈代谢学
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 败血症引起的血管损伤显著导致死亡率,由于对分子机制的了解不足,有效治疗方法有限.
- 伊塔科尼酸是一种内源代谢物,与炎症性疾病有关,但其在败血症引起的血管损伤中的具体作用尚不清楚.
研究的目的:
- 为了研究4-octyl itaconate (4-OI) 的治疗效果,一个细胞透的伊塔康酸衍生物,在败血症引起的血管损伤和器官损伤上.
- 阐明4-OI对内皮炎症和屏障功能障碍的保护作用背后的分子机制.
主要方法:
- 在体外研究中使用了用脂聚糖 (LPS) 处理的人体静脉内皮细胞 (HUVEC) 来评估炎症标志物,氧化应激,亡,烧亡,细胞粘附和屏障透性.
- 在体内验证使用LPS诱导的败血症小鼠模型进行,以评估炎症性细胞因子水平,肺,血管泄漏,组织损伤和生存率.
- 使用了定量逆转录聚合酶连锁反应 (qRT-PCR),酶相关免疫吸收测试 (ELISA),西部涂抹和各种光探针测试.
主要成果:
- 4-OI显著抑制了LPS诱导的促炎性细胞因子 (TNF-α,IL-6,IL-1β) 的增加,并抑制了氧化应激,包括线粒体活性氧物种 (ROS) 和线粒体功能障碍.
- 通过降低ICAM-1和VCAM-1表达的调节,4-OI治疗减少了内皮细胞的亡,烧亡和细胞粘附,同时通过VE-cadherin稳定性保持内皮屏障完整性.
- 在体内,4-OI预治疗减少了全身和肺炎,减少了肺和血管泄漏,减轻了肺组织损伤,并在败血症诱导的急性肺损伤 (ALI) 鼠标模型中提高了生存率.
结论:
- 4-octyl itaconate (4-OI) 显示出显著的保护作用,防止败血症引起的血管损伤和器官损伤.
- 该机制涉及抑制内皮炎症,减轻氧化应激,并保持内皮屏障完整性.
- 4-OI代表了一种潜在的治疗药物,用于治疗与败血症相关的并发症.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.1K
01:26Acute Inflammation I: Inflammatory Response
94
Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect...
94
01:25Acute Inflammation II: Local and Systemic Effects
56
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
56
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
34
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34